Nanomedicine Research Group

Our research is focused on the roles of lipids in biological membranes and the use of liposomal nanoparticulate (LN) systems to deliver conventional and genetic drugs. Our interests in LN systems can be divided into three parts:

The delivery of small molecule drugs, particularly those used in cancer chemotherapy, with the aim of increasing efficacy and reducing toxicity... (read more)

The delivery of LN encapsulated immunostimulatory oligonucleotides to cells of the immune system, as an adjuvant for the immunotherapy of infectious and malignant disease... (read more)

The design of LN systems capable of effectively delivering macromolecules such as siRNA to target cells in vivo following systemic administration... (read more)